Table: q1_q4_2022_prescription_drug_wac_increases , manufacturer_name like X*

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  *

oshpd_id	manufacturer_name	date_reported	ndc_number	drug_product_description	wac_effective_date	wac_increase_amount	wac_after_increase	patent_expiration_date	drug_source_type	unit_sales_volume_in_us	unit_sales_volume_non_public_indicator	cost_increase_factors	cost_increase_factors_non_public_indicator	change_improvement_description	change_improvement_non_public_indicator	acquisition_date	company_acquired_from	acquisition_price	acquisition_price_non_public_indicator	acquisition_price_comment	wac_at_acquisition	wac_year_prior_to_acquisition	year_drug_introduced_to_market	wac_at_intro_to_market	supporting_documents	general_comments
Rx0000380	Xeris Pharmaceuticals, INC.	03/31/2022	71090000101	Keveyis (dichlorphenamide) oral tablet, 50mg, Bottle of 100	02/01/2022	2471.36	27434.64	08/07/2022	Single Source Drug	None	1	None	1	None	1	12/12/2016	Taro Pharmaceuticals Industries	8500000	None	None	13650.00	13650.00	2015	13650.00	None	None
Rx0000380	Xeris Pharmaceuticals, INC.	09/30/2022	71090000101	Keveyis (dichlorphenamide) oral tablet, 50mg, Bottle of 100	08/01/2022	2716.03	30150.67	08/07/2022	Single Source Drug	None	1	None	1	None	1	None	None	None	None	None	None	None	None	None	None	None
Rx0000380	Xeris Pharmaceuticals, INC.	12/31/2022	72065000301	Levoketoconazole (Recorlev) 150 MG/1 Oral Tablet 50 tablets in 1 bottle	12/30/2022	1468.81	16305.31	03/02/2040	Single Source Drug	None	1	None	1	None	1	None	None	None	None	None	None	None	None	None	None	None